Reports for GE HEALTHCARE CANADA INC
Company Name
GE HEALTHCARE CANADA INC
Shortage reports
Actual shortage:
2 (2%)
Anticipated shortage:
0 (0%)
Avoided shortage:
6 (6%)
Resolved:
93 (92%)
101
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
5 (100%)
Reversed:
0 (0%)
5
0 (0%)
2 (100%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-05-28 | 2024-06-12 | 229037 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-09-16 | 2024-09-21 | 237683 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2024-09-17 | 2024-09-28 | 237809 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Resolved | 2025-01-24 | 2025-03-04 | 248506 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Actual shortage | 2025-05-02 | 2025-05-03 | 256577 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2021-08-18 | 2021-08-25 | 144299 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-04-01 | 2022-04-19 | 157813 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-12 | 2023-03-01 | 160389 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-07 | 160534 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-17 | 160537 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160540 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-17 | 160562 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2024-01-26 | 2024-02-15 | 217411 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2024-01-26 | 2024-02-24 | 217417 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2025-04-16 | 2025-04-22 | 255152 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2021-08-06 | 2021-08-13 | 143789 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-04-11 | 2022-04-22 | 158491 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-17 | 160543 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160546 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160549 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| Metastron | 37 MBq/mL | Solution | Discontinued | 2018-10-12 | 2019-02-01 | 63929 |
| OMNIPAQUE 180 | 388MG | SOLUTION | Discontinued | 2023-01-31 | 2023-02-22 | 182757 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-18 | 182760 |
| OMNISCAN | 287MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-25 | 182742 |
| THALLOUS CHLORIDE TI 201 INJECTION | 37MBq | SOLUTION | Discontinued | 2020-12-04 | 2021-06-05 | 129592 |
Showing 1 to 5 of 5